Part Number
Part Number:
NSN:
NIIN:
Item Name:
PANCRELIPASE DELEAYED-RELEASE CA
Definition:
CAGE Information
| Code | Company |
|---|---|
| 0TX62 | AXCAN PHARMA US INC. |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| FEAT | SPECIAL FEATURES | CONTAINS 20,000 USP UNITS LIPASE ACTIVE INGREDIENT,65,000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 65,0000 USP UNITS PROTEASE ACTIVE INGREDIENT; ENTERIC COATED |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |